01jun

Diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in clinical practice: a survey among Dutch neurologists.

Auteurs: Broers MC, van Doorn PA, Kuitwaard K, Eftimov F, Wirtz PW, Goedee S, Lingsma HF, Jacobs BC.
01jun

Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study.

Auteurs: Haasnoot KJC, Backes Y, Moons LMG, Kranenburg O, Trinh A, Vermeulen L, Noë M, Tuynman JB, van Lent AUG, van Ginneken R, Seldenrijk CA, Raicu MG, Trumpi K, Ubink I, Milne AN, Boonstra JJ, Groen JN, Schwartz MP, Wolfhagen FHJ, Geesing JMJ, Ter Borg F, Brosens LAA, van Bergeijk J, Spanier BWM, de Vos Tot Nederveen Cappel WH, Kessels K, Seerden TCJ, Vleggaar FP, Offerhaus GJA, Siersema PD, Elias SG, Laclé MM; Dutch T1 CRC Working Group.
01jun

A new gene associated with a beta-thalassemia phenotype: the observation of variants in SUPT5H.

Auteurs: Achour A, Koopmann TT, Castel R, Santen GWE, Hollander den N, Knijnenburg J, Ruivenkamp CAL, Arkesteijn SGJ, Huurne Ter J, Bisoen S, Verschuren M, Vijfhuizen L, Schaap R, Grimbergen A, Slomp J, Traeger-Synodinos J, Vrettou C, Pissard S, Galactéros F, Baas F, Harteveld CL.
01jun

Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2017.

Auteurs: Ector GICG, Visser O, Westerweel PE, Janssen JJWM, Blijlevens NMA, Dinmohamed AG.
01jun

Response and Adherence to Nilotinib in Daily Practice (RAND Study): An In-Depth Observational Study of Chronic Myeloid Leukemia Patients Treated With Nilotinib.

Auteurs: Christel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, Peter E Westerweel, Nicole M A Blijlevens, Willem M Smit, Imke H Bartelink, Janneke A Wilschut, Eleonora L Swart, N Harry Hendrikse, Jacqueline G Hugtenburg.